Streetbeat News

Analyst Ratings

CUZ

Evercore ISI Group has maintained its Outperform rating for Cousins Props (NYSE:CUZ) and raised its price target from $25.00 to $28.00. This would represent a 26.13% increase from the current share price. Cousins Properties Inc is a real estate investment trust mainly involved in the ownership, management, and development of properties in the Southern United States.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 5:00 pm

HPQ

HP's (NYSE:HPQ) short percent of float has fallen 31.4% since its last report, with 12.29 million shares sold short, which is 1.42% of all regular shares available for trading. It would take traders 2.9 days to cover their short positions on average. The decrease in short interest can signal that investors have become more bullish. HP's peer group average for short interest as a percentage of float is 6.37%, indicating that the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 5:00 pm

ETR

JP Morgan has maintained its Overweight rating for Entergy (NYSE:ETR) and increased its price target from $121.00 to $124.00. Entergy's shares are currently trading up 0.51% at $96.07 per share. A move to $124.00 would represent a 29.07% increase from the current share price.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 5:00 pm

JWN

In the last quarter, Nordstrom (NYSE:JWN) received 6 indifferent and 2 somewhat bearish analyst ratings. Over the past 3 months, 8 analysts have offered 12-month price targets for Nordstrom, with an average price target of $18.75, up by 9.01% from the previous average of $17.20.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 5:00 pm

FL

BTIG has maintained its Buy rating for Foot Locker (NYSE:FL) but lowered its price target from $42.00 to $35.00. Foot Locker's shares are currently trading at $25.25, meaning a move to $35.00 would represent a 38.59% increase.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 5:00 pm

JD

A significant bullish stance has been taken on JD.com (NASDAQ:JD) as evidenced by unusual options activity. The overall sentiment of these big-money traders is split between 64% bullish and 35% bearish. The whales have been targeting a price range from $27.5 to $50.0 for JD.com over the last 3 months. B of A Securities, Mizuho, and Citigroup have all maintained their Buy rating on JD.com with price targets of $51, $60, and $64 respectively.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 4:46 pm

CAT

A significant amount of unusual options activity has been observed for Caterpillar (NYSE:CAT), with a majority of investors taking a bearish stance. The price target for Caterpillar, based on volume and open interest, ranges from $240 to $370. The current price of CAT is $277.89, up 1.23%. Several financial institutions have maintained their ratings on Caterpillar, with price targets ranging from $250 to $323. The next earnings are expected in 70 days.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 4:45 pm

BKNG

A significant bearish stance has been taken on Booking Holdings (NASDAQ:BKNG) by a large investor, as observed in the unusual options activity. The sentiment among these big-money traders is split between 21% bullish and 78% bearish. The whales have been targeting a price range from $2740.0 to $3800.0 for Booking Holdings over the last 3 months. The price of BKNG is currently down -1.38% at $3151.17. Several financial institutions have maintained their positive ratings on Booking Holdings with price targets ranging from $2800 to $3740.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 4:45 pm

SLN

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Silence Therapeutics (NASDAQ:SLN) and maintained a price target of $80.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 4:42 pm

MDT

Medtronic Plc (NYSE:MDT) is set to report its Q1 FY24 earnings on 8/22/23. Analysts from Needham expect the company to beat consensus revenue and EPS due to strong elective procedure growth and conservative guidance from management. They also anticipate a raise in FY24 guidance. Medtronic's strategy includes mergers, acquisitions, and divestitures to boost its market growth rate. The company's shares are currently up 0.39% at $81.89.

Portfolio Pulse from Vandana Singh

August 17, 2023 | 4:36 pm